// App-Quantinova.ai

: 10 years’ experience of referral of ILD patients with Suspected PH to a National PH Service: Demographics and Outcomes

Researchers

Presenter

  • Simon Bax

Principal Investigators

  • Vasilis Kouranos

  • Charlene Bredy

  • Konstantinos Dimopoulos

  • Aleksander Kempny

  • Simon Walsh

  • Arjun Nair

  • Maria Kokosi

  • Gregory Kier

  • Elisabetta Renzoni

  • Felix Chua

  • Peter George

  • Colm Mccabe

  • Michael Wilde

  • Arnie Devaraj

  • Athol Wells

  • Laura Price

  • S John Wort

Medical Centers

  • National Pulmonary Hypertension Service, Royal Brompton and Harefield NHS Trust, London, United Kingdom

  • Department of Radiology, Royal Brompton and Harefield NHS Foundation Trust, London, United Kingdom,

  • Department of Interstitial Lung Diseases, Royal Brompton and Harefield NHS Trust, London, United Kingdom

  • Department of Radiology, Guy’s and St Thomas’ NHS foundation Trust, London, UK, London, United Kingdom

  • Department of Respiratory Medicine, King’s College Hospital NHS Foundation Trust, London, UK, London, United Kingdom

  • Princess Alexandra Hospital, Dept of Respiratory Medicine, Woolloongabba, Australia, Woolloongabba, Australia

  • Surrey and Sussex Hospital, Redhill, Surrey, Canada Ave, Redhill, UK, London, United Kingdom

Locations

  • United Kingdom

  • Australia

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Pulmonary/Respiratory Diseases

Disease

  • Chronic thromboembolic pulmonary hypertension

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A